Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Fariba

Fariba Ariaei, Middletown, PA US

Patent application numberDescriptionPublished
20090326401Method and System for Dynamical Systems Modeling of Electrocardiogram Data - Electrocardiogram data is received in association with a subject, the electrocardiogram data comprising a series of RR intervals and a series of QT intervals. A first value which indicates an amount by which uncertainty associated with the QT intervals is reduced given the RR intervals is generated. A second value which indicates an amount by which uncertainty associated with the RR intervals is reduced given the QT intervals is generated. The subject is determined to be associated with a low risk of cardiac dysfunction responsive to the first value exceeding the second value and a result of the determination is provided.12-31-2009

Fariba Ghiasi, Frankfurt DE

Patent application numberDescriptionPublished
20100293724USE PF ALKANOLAMINES FOR THICKENING OXIDATIVE COLOURING EMULSION - The present invention relates to the use of alkanolamines for thickening oxidative coloring compositions. More particularly, the present invention relates to the use of alkanolamines for thickening ready to use oxidative coloring composition based on mixing two compositions wherein one comprises at least one oxidative dyeing precursor and the other comprises as least one oxidizing agent.11-25-2010

Fariba Nayeri, Linkoping SE

Patent application numberDescriptionPublished
20080261233Assessment of Biological Activity of Hepatocyte Growth Factor (Hgf) - In the present invention the methods for recognition of biologically active hepatocyte growth factor efficient for using in therapeutic components are presented. The biological activity can be determined using: i) an in vitro model of restitution of damaged cells, and/or ii) affinity measurements or epitope mapping using SPR, with the C-met receptor, anti-HGF antibodies or polysaccharides such as dextran, and/or iii) an animal model of hair growth rates. By these methods the activity of HGF in body secretions can be evaluated as well.10-23-2008
20090068179Methods for Inhibiting Carcinogenesis and/or Metastasis in an Individual with Endogenous C-Met Ligands and Inhibitors - Methods for inhibiting carcinogenesis and/or metastasis in an individual comprise administering to the individual an effective amount of endogenous c-met ligand or fragment thereof such as endogenous anti c-met immunoglobulin, native and/or recombinant; endogenous biological active Hepatocyte Growth Factor (HGF), native and/or recombinant, and/or a combination thereof.03-12-2009
20100160223Synergetic Effects of HGF and Antibacterial Treatment - A method of treating an infection and/or an injury caused or complicated by an infection in a mammal, comprising providing an antibiotic or fungicide and either HGF or a polypeptide exhibiting HGF activity to said mammal. In one embodiment, the injury is not a chronic skin ulcer.06-24-2010

Patent applications by Fariba Nayeri, Linkoping SE

Fariba Soleymanzadeh, Danbury, CT US

Patent application numberDescriptionPublished
20080280904N-Substituted Pyridinone or Pyrimidinone Compounds Useful as Soluble Epoxide Hydrolase Inhibitors - Disclosed are compounds active against soluble epoxide hydrolase (sEH), compositions thereof and methods of using and making same.11-13-2008
20090099184Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors - Disclosed are compounds active against soluble epoxide hydrolase (sEH), compositions thereof and methods of using and making same.04-16-2009
20090111791Soluble Epoxide Hydrolase Inhibitors and Methods of Using Same - Disclosed are compounds active against soluble epoxide hydrolase (sEH), compositions thereof and methods of using and making same.04-30-2009
20100121051UROTENSIN II RECEPTOR ANTAGONISTS - Compounds of the formula (I)05-13-2010
20110118262Pyrrolidinyl and Piperidinyl Compounds Useful as NHE-1 Inhibitiors - Disclosed are compounds of formula (I) and compositions of the present invention which are inhibitors of the sodium proton exchanger isoform-1 (NHE-I). Also disclosed are methods of using and making the same.05-19-2011

Patent applications by Fariba Soleymanzadeh, Danbury, CT US

Fariba Tajabadi, Kerman IR

Patent application numberDescriptionPublished
20110220192SINGLE-SIDED DYE-SENSITIZED SOLAR CELLS HAVING A VERTICAL PATTERNED STRUCTURE - A single-sided dye-sensitized solar cell having a vertical patterned structure is disclosed. A patterned nonconductive insulating layer is formed directly over first portions of a conductive substrate. An electrocatalyst material layer is formed directly over second portions of the conductive substrate, where the second portions of the conductive substrate do not overlap with the first portions of the conductive substrate. A second conductive layer is formed directly over the patterned nonconductive insulating layer and a porous layer is formed directly over the second conductive layer. An electrolyte is formed over the porous layer and the electrocatalyst material layer and a transparent sheet is formed over the electrolyte.09-15-2011